Evidence map›Paper›PMID 30108903›Full record

ArticleMedChemComm2018

A β-carboline derivative-based nickel(ii) complex as a potential antitumor agent: synthesis, characterization, and cytotoxicity.

Jing-Mei Yang, Yan-Hong Zhu, Sheng Chen, Xing Lu, Yi-Ming Wu, Feng-E Ma, Liang-Ping Li, Yang Yang, Zhen-Hao Shi, Kun-Yuan Huang and 3 more

Abstract read
In one paragraph

Article in MedChemComm, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Jing-Mei YangState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources , School of Chemistry and Pharmacy , Guangxi Normal University , No. 15 Yucai Road , Guilin 541004 , China . Email: pengyan630@aliyun.com ; ; Tel: +86 773 2120958.
Yan-Hong ZhuState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources , School of Chemistry and Pharmacy , Guangxi Normal University , No. 15 Yucai Road , Guilin 541004 , China . Email: pengyan630@aliyun.com ; ; Tel: +86 773 2120958.
Sheng ChenState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources , School of Chemistry and Pharmacy , Guangxi Normal University , No. 15 Yucai Road , Guilin 541004 , China . Email: pengyan630@aliyun.com ; ; Tel: +86 773 2120958.
Xing LuState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources , School of Chemistry and Pharmacy , Guangxi Normal University , No. 15 Yucai Road , Guilin 541004 , China . Email: pengyan630@aliyun.com ; ; Tel: +86 773 2120958.
Yi-Ming WuState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources , School of Chemistry and Pharmacy , Guangxi Normal University , No. 15 Yucai Road , Guilin 541004 , China . Email: pengyan630@aliyun.com ; ; Tel: +86 773 2120958.
Feng-E MaState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources , School of Chemistry and Pharmacy , Guangxi Normal University , No. 15 Yucai Road , Guilin 541004 , China . Email: pengyan630@aliyun.com ; ; Tel: +86 773 2120958.
Liang-Ping LiState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources , School of Chemistry and Pharmacy , Guangxi Normal University , No. 15 Yucai Road , Guilin 541004 , China . Email: pengyan630@aliyun.com ; ; Tel: +86 773 2120958.
Yang YangState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources , School of Chemistry and Pharmacy , Guangxi Normal University , No. 15 Yucai Road , Guilin 541004 , China . Email: pengyan630@aliyun.com ; ; Tel: +86 773 2120958.
Zhen-Hao ShiState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources , School of Chemistry and Pharmacy , Guangxi Normal University , No. 15 Yucai Road , Guilin 541004 , China . Email: pengyan630@aliyun.com ; ; Tel: +86 773 2120958.
Kun-Yuan HuangState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources , School of Chemistry and Pharmacy , Guangxi Normal University , No. 15 Yucai Road , Guilin 541004 , China . Email: pengyan630@aliyun.com ; ; Tel: +86 773 2120958.
Xue HongState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources , School of Chemistry and Pharmacy , Guangxi Normal University , No. 15 Yucai Road , Guilin 541004 , China . Email: pengyan630@aliyun.com ; ; Tel: +86 773 2120958.
Ping JiangShanghai Mental Health Center , Shanghai Institute of Mental Health , Shanghai Jiao Tong University School of Medicine , 600 Wan Ping Nan Road , Shanghai 200030 , P.R. China . Email: jiangping413@126.com ; ; Tel: +86 21 64387250.
Yan PengState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources , School of Chemistry and Pharmacy , Guangxi Normal University , No. 15 Yucai Road , Guilin 541004 , China . Email: pengyan630@aliyun.com ; ; Tel: +86 773 2120958.ORCID 0000-0001-6579-3409
Guangxi Normal University · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel nickel(ii) complex of 6-methoxy-1-pyridine-β-carboline (

Identifiers

PMID30108903
PMCPMC6072409
OpenAlexW2770287604

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.